Mandate

Vinge advises Oberthur Technologies in public offer for XPonCard

February 27, 2008

Vinge is advising Oberthur Technologies in connection with its announced public offer for XPonCard Group AB (publ). The offer, which comprises all shares in XPonCard, values XPonCard at approximately SEK 704 million.

The Vinge team advising Oberthur Technologies S.A. includes Anders Åberg, Jan Lombach, Mattias Friberg and Petter Elmstedt. Paula Röttorp, Louise Salomon and Anders Morén are providing advice regarding the financing, and Mattias Schömer and Johan Bocander are providing tax advice. Emma Dufva is providing competition law advice.

Oberthur Technologies is listed on Euronext Paris. Oberthur Technologies is one of the world leaders in the field of secure technologies in its main target markets: smart cards, secure printing and cash protection. XPonCard is a services company listed on OMX Nordic Exchange Stockholm that provides card concepts and solutions for secure payment, smart mobile solutions, improved customer loyalty and secure identification. The combination of Oberthur Technologies and XPonCard will create the second largest player in the global smart card industry with sales in the order of EUR 735 million (SEK 6.8 billion).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026